These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 34757877)

  • 1. Approach to Pediatric Obesity and Nonalcoholic Fatty Liver Disease.
    Ascher Bartlett JM; Mittal N
    Pediatr Ann; 2021 Nov; 50(11):e474-e477. PubMed ID: 34757877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty liver disease and obesity in youth.
    Della Corte C; Mazzotta AR; Nobili V
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):66-71. PubMed ID: 26702852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in diagnosis and treatment of nonalcoholic fatty liver disease].
    Zhu C; Zhou D; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):81-4. PubMed ID: 26983471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic Fatty Liver Disease in Children.
    Mann JP; Valenti L; Scorletti E; Byrne CD; Nobili V
    Semin Liver Dis; 2018 Feb; 38(1):1-13. PubMed ID: 29471561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in Screening for Pediatric Nonalcoholic Fatty Liver Disease.
    Ferguson AE; Xanthakos SA; Siegel RM
    Clin Pediatr (Phila); 2018 May; 57(5):558-562. PubMed ID: 29022357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice.
    Zhou JH; Cai JJ; She ZG; Li HL
    World J Gastroenterol; 2019 Mar; 25(11):1307-1326. PubMed ID: 30918425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease.
    Lin CH; Kohli R
    Curr Gastroenterol Rep; 2020 Aug; 22(10):52. PubMed ID: 32814993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease.
    Satapathy SK; Sanyal AJ
    Semin Liver Dis; 2015 Aug; 35(3):221-35. PubMed ID: 26378640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
    Goldner D; Lavine JE
    Gastroenterology; 2020 May; 158(7):1967-1983.e1. PubMed ID: 32201176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
    Perumpail RB; Wong RJ; Ahmed A; Harrison SA
    Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity-fatty liver: the role of the pediatrician].
    Ciocca M; Álvarez F
    Arch Argent Pediatr; 2021 Dec; 119(6):427-430. PubMed ID: 34813249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation.
    Younossi ZM
    Liver Transpl; 2018 Feb; 24(2):166-170. PubMed ID: 29272073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nonalcoholic fatty liver disease and liver cancer.
    Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
    World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An interpretation of the AASLD practice guideline on the diagnosis and management of nonalcoholic fatty liver disease in 2017].
    Nan YM; Fu N; Li WC; Kong LL; Yuan XW; Zhang SY; Liu LD; Lu Y; Cui LY
    Zhonghua Gan Zang Bing Za Zhi; 2017 Sep; 25(9):687-694. PubMed ID: 29108191
    [TBL] [Abstract][Full Text] [Related]  

  • 16.  Most overweight and obese Indian children have nonalcoholic fatty liver disease.
    Pawar SV; Zanwar VG; Choksey AS; Mohite AR; Jain SS; Surude RG; Contractor QQ; Rathi PM; Verma RU; Varthakavi PK
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):853-861. PubMed ID: 27740518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial Issues in Pediatric Nonalcoholic Fatty Liver Disease.
    Karaivazoglou K; Kalogeropoulou M; Assimakopoulos S; Triantos C
    Psychosomatics; 2019; 60(1):10-17. PubMed ID: 30318268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the pathogenic and therapeutic role of nutrition in pediatric nonalcoholic fatty liver disease.
    Panera N; Barbaro B; Della Corte C; Mosca A; Nobili V; Alisi A
    Nutr Res; 2018 Oct; 58():1-16. PubMed ID: 30340810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence and harm of nonalcoholic fatty liver disease].
    Shao YL; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):10-13. PubMed ID: 30685917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence.
    Temple JL; Cordero P; Li J; Nguyen V; Oben JA
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27314342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.